MedTrace Logo

Safety and Efficiency of Combined Extracorporeal Blood Purification in Neurosurgical ICU. Prospective RCT

NCT04152174 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2021-09-05

No results posted yet for this study

Summary

To assess the efficiency and safety of combined extracorporeal blood purification in patients with septic shock in Neurosurgical ICU in comparison with the efficiency and safety of the continuous renal replacement therapy (CRRT).

Conditions

  • Septic Shock

Interventions

PROCEDURE

Combined extracorporeal blood purification

Patients receive combined extracorporeal blood purification: CRRT in CVVHDF mode with AN 69 ST set (Baxter) and hemoadsorption with Cytosorbents Corp. CytoSorb adsorber.

PROCEDURE

CRRT

Patients receive CRRT in CVVHDF mode with AN 69 ST set (Baxter)

Sponsors & Collaborators

  • Burdenko Neurosurgery Institute

    lead OTHER

Principal Investigators

  • Aleksandr Burov · N. N. Burdenko National Medical Research Center of Neurosurgery

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-10
Primary Completion
2021-09-10
Completion
2021-11-10

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04152174 on ClinicalTrials.gov